A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus

Clinical trial NCT05687526 · COMPLETED

Trial details

NCT number: NCT05687526
Sponsor: RemeGen Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2023-05-25
Primary completion: 2025-11-14
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.